Increased expression of H19/miR-675 is associated with a low fat-free mass index in patients with COPD

Journal of Cachexia, Sarcopenia and Muscle

Volumn , Issue , 2016, Pages 330-344

  Lewis, Amy ^a   Lee, Jen Y ^a   Donaldson, Anna V ^a,b   Natanek, S Amanda ^a,b   Vaidyanathan, Srividya ^a   Man, William D C ^b   Hopkinson, Nicholas S ^b   Sayer, Avan A ^c   Patel, Harnish P ^c   Cooper, Cyrus ^c   Syddall, Holly ^c   Polkey, Michael I ^b   Kemp, Paul R ^a  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b ROYAL BROMPTON AND HAREFIELD NHS FOUNDATION TRUST   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

Author keywords

Cell proliferation; MiRNA; Regeneration; Skeletal muscle

Indexed keywords

LONG UNTRANSLATED RNA; MICRORNA; MICRORNA 519A; MICRORNA 675; RNA H19; UNCLASSIFIED DRUG;

AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FAT FREE MASS; FAT FREE MASS INDEX; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOFLUORESCENCE TEST; IN VITRO STUDY; MALE; MUSCLE MASS; MUSCLE REGENERATION; MUSCLE STRENGTH; MUSCLE WEAKNESS; MYOBLAST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUADRICEPS FEMORIS MUSCLE; RNA METHYLATION;

EID: 84978919483     PISSN: 21905991     EISSN: 21906009     Source Type: Journal    
DOI: 10.1002/jcsm.12078     Document Type: Article

References (46)

1. Swallow EB, Reyes D, Hopkinson NS, Man WD, Porcher R, Cetti EJ et al. Quadriceps strength predicts mortality in patients with moderate to severe chronic obstructive pulmonary disease. Thorax 2007;62:115–120.
2. Marquis K, Debigare R, Lacasse Y, LeBlanc P, Jobin J, Carrier G et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002;166:809–813.
3. Shrikrishna D, Patel M, Tanner RJ, Seymour JM, Connolly BA, Puthucheary ZA et al. Quadriceps wasting and physical inactivity in patients with COPD. Eur Respir J 2012;40:1115–1122.
4. Natanek SA, Gosker HR, Slot IG, Marsh GS, Hopkinson NS, Man WD-C et al. Heterogeneity of quadriceps muscle phenotype in chronic obstructive pulmonary disease (COPD); implications for stratified medicine? Muscle Nerve 2013;48:488–497.
5. Lacasse Y, Brosseau L, Milne S, Martin S, Wong E, Guyatt GH et al. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2002;3CD003793:doi:10.1002/14651858.CD003793.
6. Dodd JW, Hogg L, Nolan J, Jefford H, Grant A, Lord VM et al. The COPD assessment test (CAT): response to pulmonary rehabilitation. A multicentre, prospective study. Thorax 2011;66:425–429.
7. Sandri M . Signaling in muscle atrophy and hypertrophy. Physiology (Bethesda) 2008;23:160–170.
8. Sayer AA, Dennison EM, Syddall HE, Jameson K, Martin HJ, Cooper C . The developmental origins of sarcopenia: using peripheral quantitative computed tomography to assess muscle size in older people. J Gerontol A Biol Sci Med Sci 2008;63:835–840.
9. Sayer AA, Syddall H, Martin H, Patel H, Baylis D, Cooper C . The developmental origins of sarcopenia. J Nutr Health Aging 2008;12:427–432.
10. van Rooij E, Liu N, Olson EN . MicroRNAs flex their muscles. Trends Genet 2008;24:159–166.
11. Lewis A, Riddoch-Contreras J, Natanek SA, Donaldson A, Man WD, Moxham J et al. Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD. Thorax 2012;67:26–34.
12. Eisenberg I, Eran A, Nishino I, Moggio M, Lamperti C, Arnato AA et al. Distinctive patterns of microRNA expression in primary muscular disorders. Proc Natl Acad Sci U S A 2007;104:17016–17021.
13. van Rooij E, Quiat D, Johnson BA, Sutherland LB, Qi X, Richardson JA et al. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev Cell 2009;17:662–673.
14. Nielsen S, Scheele C, Yfanti C, Akerstrom T, Nielsen AR, Pedersen BK et al. Muscle specific microRNAs are regulated by endurance exercise in human skeletal muscle. J PhysiolLondon 2010;588:4029–4037.
15. Etheridge A, Lee I, Hood L, Galas D, Wang K . Extracellular microRNA: a new source of biomarkers. Mutat Res 2011;717:85–90.
16. Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, Hofstra L et al. Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet 2010;3:499–506.
17. Donaldson A, Natanek SA, Lewis A, Man WD, Hopkinson NS, Polkey MI et al. Increased skeletal muscle-specific microRNA in the blood of patients with COPD. Thorax 2013;68:1140–1149.
18. Lujambio A, Calin GA, Villanueva A, Ropero S, Sanchez-Cespedes M, Blanco D et al. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci U S A 2008;105:13556–13561.
19. Minor J, Wang X, Zhang F, Song J, Jimeno A, Wang XJ et al. Methylation of microRNA-9 is a specific and sensitive biomarker for oral and oropharyngeal squamous cell carcinomas. Oral Oncol 2012;48:73–78.
20. Rotkrua P, Akiyama Y, Hashimoto Y, Otsubo T, Yuasa Y . MiR-9 downregulates CDX2 expression in gastric cancer cells. Int J Canc Suppl J Int Canc 2011;129:2611–2620.
21. Noguer-Dance M, Abu-Amero S, Al-Khtib M, Lefevre A, Coullin P, Moore GE et al. The primate-specific microRNA gene cluster (C19MC) is imprinted in the placenta. Hum Mol Genet 2010;19:3566–3582.
22. Seitz H, Royo H, Bortolin ML, Lin SP, Ferguson-Smith AC, Cavaille J . A large imprinted microRNA gene cluster at the mouse Dlk1-Gtl2 domain. Genome Res 2004;14:1741–1748.
23. Pachnis V, Belayew A, Tilghman SM . Locus unlinked to alpha-fetoprotein under the control of the murine raf and Rif genes. Proc Natl Acad Sci U S A 1984;81:5523–5527.
24. Dey BK, Pfeifer K, Dutta A . The H19 long noncoding RNA gives rise to microRNAs miR-675-3p and miR-675-5p to promote skeletal muscle differentiation and regeneration. Genes Dev 2014;28:491–501.
25. Lee KW, Pausova Z . Cigarette smoking and DNA methylation. Front Genet 2013;4:132, doi:10.3389/fgene.2013.00132.
26. Terruzzi I, Senesi P, Montesano A, La Torre A, Alberti G, Benedini S et al. Genetic polymorphisms of the enzymes involved in DNA methylation and synthesis in elite athletes. Physiol Genomics 2011;43:965–973.
27. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007;176:532–555.
28. Schols AM, Soeters PB, Dingemans AM, Mostert R, Frantzen PJ, Wouters EF . Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis 1993;147:1151–1156.
29. Wanger J, Clausen JL, Coates A, Pedersen OF, Brusasco V, Burgos F et al. Standardisation of the measurement of lung volumes. Eur Respir J 2005;26:511–522.
30. Steiner MC, Barton RL, Singh SJ, Morgan MD . Bedside methods versus dual energy X-ray absorptiometry for body composition measurement in COPD. Eur Respir J 2002;19:626–631.
31. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med 2002;166:111–117.
32. Bergstrom J . Percutaneous needle biopsy of skeletal muscle in physiological and clinical research. Scand J Clin Lab Invest 1975;35:609–616.
33. Patel HP, Jameson KA, Syddall HE, Martin HJ, Stewart CE, Cooper C et al. Developmental influences, muscle morphology, and sarcopenia in community-dwelling older men. J Gerontol A Biol Sci Med Sci 2012;67:82–87.
34. Patel H, Syddall HE, Martin HJ, Cooper C, Stewart C, Sayer AA . The feasibility and acceptability of muscle biopsy in epidemiological studies: findings from the Hertfordshire Sarcopenia Study (HSS). J Nutr Health Aging 2011;15:10–15.
35. Ellis PD, Smith CW, Kemp P . Regulated tissue-specific alternative splicing of enhanced green fluorescent protein transgenes conferred by alpha-tropomyosin regulatory elements in transgenic mice. J Biol Chem 2004;279:36660–36669.
36. Morales-Prieto DM, Ospina-Prieto S, Chaiwangyen W, Schoenleben M, Markert UR . Pregnancy-associated miRNA-clusters. J Reprod Immunol 2013;97:51–61.
37. Rippe V, Dittberner L, Lorenz VN, Drieschner N, Nimzyk R, Sendt W et al. The two stem cell microRNA gene clusters C19MC and miR-371-3 are activated by specific chromosomal rearrangements in a subgroup of thyroid adenomas. PLoS One 2010;5:e9485, doi:10.1371/journal.pone.0009485.
38. Keniry A, Oxley D, Monnier P, Kyba M, Dandolo L, Smits G et al. The H19 lincRNA is a developmental reservoir of miR-675 that suppresses growth and Igf1r. Nat Cell Biol 2012;14:659–665.
39. Fowden AL, Sibley C, Reik W, Constancia M . Imprinted genes, placental development and fetal growth. Horm Res 2006;65:50–58.
40. Sartori R, Schirwis E, Blaauw B, Bortolanza S, Zhao J, Enzo E et al. BMP signaling controls muscle mass. Nat Genet 2013;45:1309–1318.
41. Kleinman CL, Gerges N, Papillon-Cavanagh S, Sin-Chan P, Pramatarova A, Quang DA et al. Fusion of TTYH1 with the C19MC microRNA cluster drives expression of a brain-specific DNMT3B isoform in the embryonal brain tumor ETMR. Nat Genet 2014;46:39–44.
42. Murphy SK, Freking BA, Smith TP, Leymaster K, Nolan CM, Wylie AA et al. Abnormal postnatal maintenance of elevated DLK1 transcript levels in callipyge sheep. Mamm Genome 2005;16:171–183.
43. Berg JS, Lin KK, Sonnet C, Boles NC, Weksberg DC, Nguyen H et al. Imprinted genes that regulate early mammalian growth are coexpressed in somatic stem cells. PLoS One 2011;6:e26410, doi:10.1371/journal.pone.0026410PONE-D-11-11537.
44. Singh P, Lee DH, Szabo PE . More than insulator: multiple roles of CTCF at the H19-Igf2 imprinted domain. Front Genet 2012;3:214, doi:10.3389/fgene.2012.00214.
45. Theriault ME, Pare ME, Maltais F, Debigare R . Satellite cells senescence in limb muscle of severe patients with COPD. PLoS One 2012;7:e39124, doi:10.1371/journal.pone.0039124PONE-D-12-02763.
46. Bloch SA, Lee JY, Wort SJ, Polkey MI, Kemp PR, Griffiths MJ . Sustained elevation of circulating growth and differentiation factor-15 and a dynamic imbalance in mediators of muscle homeostasis are associated with the development of acute muscle wasting following cardiac surgery. Crit Care Med 2013;41:982–989.